More than 68,431 physicians have ordered Eurofins Diatherix tests since 2009.
Diatherix was founded in 2008.
Eurofins Diatherix is CAP-accredited and CLIA certified and follows the guidelines established by CAP, CLIA, and the Clinical Laboratory Standards Institute (CLSI) for validation of molecular testing technologies.
Eurofins Diatherix is a unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCR™.
Bordetella parapertussis is similar to B. pertussis and causes a pertussis-like illness. However, B. parapertussis does not produce the pertussis toxin and therefore the infections are typically milder and often asymptomatic. The CDC estimate is that B. parapertussis produces 1%-35% of infections that are ‘pertussis-like’. Given the symptoms and prevalence, our focus is on B. pertussis.
No. Diatherix Eurofins does molecular testing, not microbiological testing.
When a gene is detected on a Diatherix Eurofins Panel, the clinician should consider the presence of the particular gene identified and adjust his/her choices of antibiotics accordingly. The presence of a gene that can produce a resistance mechanism may not always be seen in phenotypic assays that are a part of routine culture and antibiotic susceptibility testing. Many of the genes that Diatherix-Eurofins Panels detect are not always expressed and may be inducible when antibiotics are used for which there is a gene present. There is no way to predict the time required to induce resistance as this may be dependent upon the concentration of antibiotic used and the duration of coverage.
Polymerase chain reaction (PCR) is a molecular biology technique that amplifies a DNA base pair sequence that is unique to the organism being identified. The DNA or RNA region of interest (usually 150-230 base pairs) is extracted from the specimen and amplified to several orders of magnitude (billions of copies). TEM-PCR™ is a proprietary technology that accomplishes the task of DNA amplification in a multiplex format; e.g. amplifying the DNA or RNA of multiple organisms in a single reaction.
Only FedEx Express® drivers will accept UN3373 Clinical Paks. FedEx Ground® drivers will not accept packages classified as such.
FedEx® routes may vary from location to location. Call 1-800-GO-FEDEX to obtain a pickup schedule for your area. Only request a FedEx Express® pickup schedule, as other FedEx® methods do not apply.
Always retain the *Keep for your records* shipping label copy from your FedEx Express® shipping label. Go to FedEx.com and type in the tracking number of your package to check the delivery status.
A FedEx® UN3373 Clinical Pak is required to ship a specimen to Diatherix. This type of packaging is not available at FedEx® locations and must be shipped to you from Diatherix. If you have run out of Clinical Paks, please call the Diatherix Logistics Department at 877-820-8047 to request an overnight shipment.
Call 877-820-8047 and request that more labels be shipped to you. If you require a label for a same day shipment, one can be emailed to you. FedEx® labels cannot be faxed due to the poor reproduction quality of fax machines.
Our packages are accepted at FedEx® main facility locations and FedEx® Drop Boxes. FedEx® Office locations WILL NOT accept this type of package. Visit FedEx.com to find a location near you.
Call 1-800-GO-FEDEX (1-800-463-3339) to schedule a pickup. Once in the automated system press ‘0’ for the first three prompts to speak with a customer service representative. Tell the representative that you have a “Prepaid FedEx Express® Label Pickup” and provide them with your address information. Write down the confirmation number for the pickup and retain it for your records.
You may use any sturdy box that you can find while we are shipping you more boxes.
Please call your Territory Manager with any issues. They will notify the Logistics Department to help resolve the issue. In most cases you will hear back from our FedEx® Representative.
If you have not received your results within 48 hours, please call Client Services at 866-979-4242
Please call Client Services at 866-979-4242 if you have not received your supplies in 3-5 business days.
Liquid Amies transport medium
Eurofins Diatherix ships the quantities ordered on the Client Supply Ordering page at: https://eurofins-diatherix.com/resources/online-supply-ordering/
All supply orders are shipped via FedEx Ground® and may take up to 3 business days to arrive. If you are out of supplies, please request FedEx Priority Overnight® delivery. Supply orders must be received by 3:00 p.m. (CST) to be processed on the same business day.
Your client number is in parenthesis next to your office name to the right of the barcode on your requisition form.
Please contact Client Services at 866-979-4242.
Client supplies can be easily ordered online at: http://eurofins-diatherix.com/resources/online-supply-ordering/
Your CLIENT ID can be located on your Eurofins Diatherix Laboratory Request form next to your company name.
Multiplex PCR tests (including TEM-PCR) can be used to assess sexual activity and confirm suspicion of the presence of sexually transmitted infections in the routine clinical setting. However, in cases of rape or sexual abuse in children under the age of 15, confirmatory testing (along with appropriate chain of custody as outlined by the CDC) should be used.
Atypical Pneumonia test
With the understanding that pharyngitis is most often caused by viruses, the Pharyngitis Panel includes Group A Strep as well as other organisms that either cause or contribute to the severity of symptoms. The Pharyngitis Plus Panel detects other bacteria that can cause pharyngitis, including those that can cause serious disease in adolescents and young adults.
Not at the present time.
Not at the present time.
Current research suggests that Toxin B, and not Toxin A is required for virulence. Given the evidence for the role of tcdB (not tcdA) in the pathophysiology of pseudomembranous colitis, we have excluded the Toxin A target from the panel. Some labs have chosen to combine Toxin A/B, and do not differentiate between the two.
Yes. The Gastrointestinal test includes Giardia lamblia and Cryptosporidium parvum.
HKU1, 229E, OC43 and NL63
Anti-herpes medications disrupt the process by which the virus makes copies of itself and spreads to new cells. The antiviral works by inhibiting an enzyme that the virus has, but human cells do not, and therefore interrupt the virus’ ability to synthesize its DNA. By reducing the replication of the Herpes virus, the number of virus particles shed by the host is reduced and tests (even molecular assays) may not always be able to detect viral shedding.
Add approximately 1mL of urine to the 1mL of fluid already in tube.
Tissue can be accepted as a specimen source but it is recommended that the tissue be pulverized/ground up before placing in collection tube. If a tissue specimen is to be submitted, please notify the laboratory prior to sending.
Not at this time.
All invoices are due within 30 days of receipt. All questions related to the client invoices may be directed to billingclients@diatherix.eurofinsus.com or 1-866-829-1854.
All calls and emails will be returned within 2 business days.
Your Client Billing Support Team members for all items related to your invoice can be reached @ billingclients@diatherix.eurofinsus.com.
Please call 1-866-829-1854, Monday-Friday between the hours of 10am-2pm CST.
All medical records are to be submitted to either the billing email @ billingmedicalrecords@diatherix.eurofinsus.com or fax at 1-256-327-5259.
Medical records are required by most payors for all pre and post payment medical record reviews.
Yes. The practitioner must separately date his/her signature authenticating an entry, even though there may already be a date on the document, since the latter may not reflect when the entry was authenticated.
Per the MLN fact Sheet: Complying with Laboratory Services/Documentation Requirements under the section Medicare Signature Requirements. “Unsigned physician orders or unsigned requisitions alone don’t support physician intent to order”.
The client will be required to submit medical records for the date of service that the request is regarding. The records will be reviewed by Billing Department leadership. The client will be notified of all request status and outcome.
The client will receive the statement for the patient visit as the insurance is listed as a Medicare Part-A status based on Medicare billing policies.
The client will receive the statement for the patients visit based on the selected bill class.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
Patients that are uninsured, symptomatic, or exposed, US citizens, and living in the United States are eligible while the program is active.
The patient will be responsible for all other tests ordered during the visit such as Respiratory testing, STD testing, GE testing, etc. based on the patients cost share defined by the patient’s individual insurance. The patient may receive a bill and be financially responsible.
For patients that are asymptomatic, non-exposed and screening is being performed for such services as pre-operative screening, screening for school, etc. you would write in the ICD-10 Diagnosis Code(s) section: PRESCREEN-Work, PRESCREEN-School, PRESCREEN-Travel, etc.
Examples include, but are not limited to the following: pre-surgical testing, school enrollment, camp entrance, employment requirement, travel requirement, patient requested testing without known exposure or symptoms, and nursing home admission requirements without symptoms and known exposure.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
Please refer to the following websites: https://www.hhs.gov/coronavirus/cares-act-provider-relief-fund/index.html, https://www.cdc.gov/coronavirus/2019-ncov/faq.html, https://www.ama-assn.org/topics/ama-covid-19-guides, and https://www.cms.gov/files/document/covid-medicare-payment-covid-19-viral-testing-flow-chart.pdf
Patients that are uninsured, symptomatic, or exposed, US citizens, and living in the United States are eligible while the program is active.
The patient will be responsible for all other tests ordered during the visit such as Respiratory testing, STD testing, GE testing, etc. based on the patients cost share defined by the patient’s individual insurance. The patient may receive a bill and be financially responsible.
If the client marks Client Bill in the Bill Class section then the client will be billed for all asymptomatic, non-exposure ICD-10-CM codes or the verbiage as noted above in the ICD-10 Diagnosis Code(s) section. The client must also have a Laboratory Service Agreement (LSA) on file to have Client Bill set up. SARS-CoV-2 single target test is currently $75/test.
Or, if the client marks Patient Self-Pay in the Bill Class section. The patient will be billed for all asymptomatic, non-exposure ICD-10-CM codes or the verbiage as noted above in the ICD-10 Diagnosis Code(s) section. SARS-CoV-2 single target test is currently $75/test.
For patients that are asymptomatic, non-exposed and screening is being performed for such services as pre-operative screening, screening for school, etc. you would write in the ICD-10 Diagnosis Code(s) section: PRESCREEN-Work, PRESCREEN-School, PRESCREEN-Travel, etc.
Examples include, but are not limited to the following: pre-surgical testing, school enrollment, camp entrance, employment requirement, travel requirement, patient requested testing without known exposure or symptoms, and nursing home admission requirements without symptoms and known exposure.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
The client will receive the statement for the visit based on the Eurofins Diatherix Policy. Please refer to the fax blast dated 2/5/2021 and 5/5/2021.
Patients that are uninsured, symptomatic, or exposed, US citizens, and living in the United States are eligible while the program is active.
The patient will be responsible for all other tests ordered during the visit such as Respiratory testing, STD testing, GE testing, etc. based on the patients cost share defined by the patient’s individual insurance. The patient may receive a bill and be financially responsible.
If the client marks Client Bill in the Bill Class section then the client will be billed for all asymptomatic, non-exposure ICD-10-CM codes or the verbiage as noted above in the ICD-10 Diagnosis Code(s) section. The client must also have a Laboratory Service Agreement (LSA) on file to have Client Bill set up. SARS-CoV-2 single target test is currently $75/test.
Or, if the client marks Patient Self-Pay in the Bill Class section. The patient will be billed for all asymptomatic, non-exposure ICD-10-CM codes or the verbiage as noted above in the ICD-10 Diagnosis Code(s) section. SARS-CoV-2 single target test is currently $75/test.
For patients that are asymptomatic, non-exposed and screening is being performed for such services as pre-operative screening, screening for school, etc. you would write in the ICD-10 Diagnosis Code(s) section: PRESCREEN-Work, PRESCREEN-School, PRESCREEN-Travel, etc.
Examples include, but are not limited to the following: pre-surgical testing, school enrollment, camp entrance, employment requirement, travel requirement, patient requested testing without known exposure or symptoms, and nursing home admission requirements without symptoms and known exposure.